Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids

Phytomedicine Plus(2024)10.1016/j.phyplu.2024.100578Source: DataRank Database

Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids is a research paper published in Phytomedicine Plus (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Alexx Weaver,Sara V. Hernandez-Madrigal ORCID,Gaurav Gajurel ORCID,Amit Raj Sharma ORCID,Fabricio Medina-Bolívar ORCID

Live enrichment

PubMed:39574482 PMC:PMC11580422 OpenAlex:https://openalex.org/W4396854998

National Institute of General Medical Sciences

Grant: 5P20 GM103429

Arkansas Biosciences Institute

Grant: 200129

NIGMS NIH HHS

Grant: P20 GM103429

National Institutes of Health

Grant: 3P20GM103429-20S1

Understanding Hesitant Adopters

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.phyplu.2024.100578

GOLDhttps://doi.org/10.1016/j.phyplu.2024.100578

publisherhttps://doi.org/10.1016/j.phyplu.2024.100578

publisherhttps://api.elsevier.com/content/article/PII:S2667031324000538?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2667031324000538?httpAccept=text/plain

Fields of Study

Sirtuins and Resveratrol in MedicineBioactive natural compoundsPlant-Derived Bioactive CompoundsMedicineEnvironmental ScienceBiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Triple-negative breast cancerPaclitaxelCytotoxic T cellTriple negativeHormone receptorBreast cancerSpheroidInternal medicineCancer researchHormoneCancerOncologyChemistryMedicineEndocrinologyIn vitroBiochemistryArachidin-1Spheroid CulturesStilbene-rich ExtractOther systems of medicineRZ201-999Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)